Compare · BTSG vs HIMS
BTSG vs HIMS
Side-by-side comparison of BrightSpring Health Services Inc. (BTSG) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTSG and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- BTSG is the larger of the two at $11.71B, about 1.8x HIMS ($6.64B).
- Over the past year, BTSG is up 152.3% and HIMS is down 31.0% - BTSG leads by 183.3 points.
- HIMS has hit the wire 27 times in the past 4 weeks while BTSG has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 23 for BTSG).
- Company
- BrightSpring Health Services Inc.
- Hims & Hers Health Inc.
- Price
- $60.25+1.81%
- $28.66+0.74%
- Market cap
- $11.71B
- $6.64B
- 1M return
- -4.03%
- -10.88%
- 1Y return
- +152.30%
- -31.04%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- 2019
- News (4w)
- 0
- 27
- Recent ratings
- 23
- 25
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest BTSG
- Amendment: SEC Form SCHEDULE 13G/A filed by BrightSpring Health Services Inc.
- SEC Form 10-Q filed by BrightSpring Health Services Inc.
- BrightSpring Health Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
- Officer Rousseau Jon B covered exercise/tax liability with 56,319 shares, decreasing direct ownership by 5% to 1,138,184 units (SEC Form 4) to cover withholding tax
- BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600
- Guggenheim initiated coverage on BrightSpring Health Services with a new price target
- Raymond James initiated coverage on BrightSpring Health Services with a new price target
- BrightSpring Health Services, Inc. to Announce Second Quarter 2026 Financial Results on July 31, 2026
- President, PharMerica Greenwell Scott A. covered exercise/tax liability with 2,487 shares, decreasing direct ownership by 7% to 34,372 units (SEC Form 4) to satisfy withholding obligation
Latest HIMS
- Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market
- Hims Arrives in Australia, Bringing Personalised Care for Men Nationwide
- Berger Montague PC Investigates Hims & Hers Health, Inc.’s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)
- Chief Executive Officer Dudum Andrew gifted 463,289 shares and disposed of 977,566 shares (SEC Form 4)
- Chief Policy Officer Autor Deborah M. sold $467,128 worth of shares (16,773 units at $27.85) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 48,961 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi sold $148,111 worth of shares (4,938 units at $29.99) as part of a pre-agreed trading plan and exercised 4,938 shares at a strike of $5.01 (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $691,808 worth of shares (25,111 units at $27.55) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 313,964 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 21,500 shares, increasing direct ownership by 7% to 339,075 units (SEC Form 4) to satisfy tax liability
- Chief Medical Officer Carroll Patrick Harrison converted options into 26,187 shares and covered exercise/tax liability with 10,201 shares, increasing direct ownership by 9% to 197,847 units (SEC Form 4) (for tax liability)
- Director Schultz Kare converted options into 6,623 shares, increasing direct ownership by 34% to 26,020 units (SEC Form 4)